TLR9 promotes tumor growth and increases chemoresistance by recognizing the specific domain of mtDNA, whereas activated NLRP3 triggers downstream signaling cascades and assembles inflammasomes via potassium ion efflux. Here, TLR9 is linked to neoplasm.